PMC:7405836 / 117918-118078 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1040","span":{"begin":22,"end":30},"obj":"Disease"},{"id":"T1041","span":{"begin":22,"end":26},"obj":"Disease"},{"id":"T1042","span":{"begin":33,"end":42},"obj":"Disease"}],"attributes":[{"id":"A1040","pred":"mondo_id","subj":"T1040","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A1041","pred":"mondo_id","subj":"T1041","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A1042","pred":"mondo_id","subj":"T1042","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"herapeutics to combat SARS-CoV-2 infection include virus binding molecules, molecules or inhibitors targeting particular enzymes implicated in replication and t"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T141","span":{"begin":51,"end":56},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"herapeutics to combat SARS-CoV-2 infection include virus binding molecules, molecules or inhibitors targeting particular enzymes implicated in replication and t"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T239","span":{"begin":65,"end":74},"obj":"Chemical"},{"id":"T240","span":{"begin":76,"end":85},"obj":"Chemical"},{"id":"T241","span":{"begin":89,"end":99},"obj":"Chemical"}],"attributes":[{"id":"A239","pred":"chebi_id","subj":"T239","obj":"http://purl.obolibrary.org/obo/CHEBI_25367"},{"id":"A240","pred":"chebi_id","subj":"T240","obj":"http://purl.obolibrary.org/obo/CHEBI_25367"},{"id":"A241","pred":"chebi_id","subj":"T241","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"herapeutics to combat SARS-CoV-2 infection include virus binding molecules, molecules or inhibitors targeting particular enzymes implicated in replication and t"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"3207","span":{"begin":22,"end":42},"obj":"Disease"}],"attributes":[{"id":"A3207","pred":"tao:has_database_id","subj":"3207","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"herapeutics to combat SARS-CoV-2 infection include virus binding molecules, molecules or inhibitors targeting particular enzymes implicated in replication and t"}